Sharon L Edelstein
Overview
Explore the profile of Sharon L Edelstein including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
65
Citations
2344
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Munshi M, Venditti E, Tjaden A, Knowler W, Boyko E, Middelbeek R, et al.
Front Public Health
. 2025 Jan;
12():1470035.
PMID: 39744353
Objectives: Type 2 diabetes (T2D) and prediabetes are associated with poor walking endurance, a marker of physical function. We aimed to examine the long-term effects of metformin or intensive lifestyle...
2.
Schmitz K, Brown J, Irwin M, Robien K, Scott J, Berger N, et al.
J Natl Cancer Inst
. 2024 Aug;
117(1):9-19.
PMID: 39118255
Chemotherapy treatment-related side effects are common and increase the risk of suboptimal outcomes. Exercise interventions during cancer treatment improve self-reported physical functioning, fatigue, anxiety, and depression, but it is unclear...
3.
Shapiro A, Tjaden A, Edelstein S, Kahn S, Srikanthan P, Knowler W, et al.
J Diabetes Complications
. 2024 May;
38(6):108764.
PMID: 38701667
Objective: Dysglycemia is a significant risk factor for cognitive impairment. However, which pathophysiologic determinant(s) of dysglycemia, impaired insulin sensitivity (ISens) or the islet β-cell's response (IResp), contribute to poorer cognitive...
4.
Lee C, Ciarleglio A, Edelstein S, Crandall J, Dabelea D, Goldberg R, et al.
Diabetes Care
. 2024 Mar;
47(5):810-817.
PMID: 38502874
Objective: To assess associations between distal symmetric polyneuropathy (DSPN) and Diabetes Prevention Program (DPP) treatment groups, diabetes status or duration, and cumulative glycemic exposure approximately 21 years after DPP randomization....
5.
Berry A, Tjaden A, Renteria J, Friedman-Klabanoff D, Hinkelman A, Gibbs M, et al.
Vaccine X
. 2023 Aug;
15:100371.
PMID: 37649617
Introduction: High levels of immunity to SARS-CoV-2 in the community correlate with protection from COVID-19 illness. Measuring COVID-19 antibody seroprevalence and persistence may elucidate the level and length of protection...
6.
Datar R, Fette L, Hinkelman A, Hammershaimb E, Friedman-Klabanoff D, Mongraw-Chaffin M, et al.
Vaccine
. 2023 Apr;
41(20):3204-3214.
PMID: 37069033
Introduction: Vaccine hesitancy presents a challenge to COVID-19 control efforts. To identify beliefs associated with delayed vaccine uptake, we developed and implemented a vaccine hesitancy survey for the COVID-19 Community...
7.
Tjaden A, Edelstein S, Arslanian S, Barengolts E, Caprio S, Cree-Green M, et al.
J Clin Endocrinol Metab
. 2023 Mar;
108(10):e1125-e1133.
PMID: 36938582
Aims: Previous work found poor reproducibility for measures of glycemia in individuals at risk for dysglycemia. Differences between youth and adults have not been assessed. Using youth and adults in...
8.
Tjaden A, Edelstein S, Ahmed N, Calamari L, Dantuluri K, Gibbs M, et al.
Influenza Other Respir Viruses
. 2023 Jan;
17(1):e13080.
PMID: 36606308
Background: Face masks have been recommended to reduce SARS-CoV-2 transmission. However, evidence of the individual benefit of face masks remains limited, including by vaccination status. Methods: As part of the...
9.
DeWitt M, Tjaden A, Herrington D, Schieffelin J, Gibbs M, Weintraub W, et al.
Emerg Infect Dis
. 2022 Dec;
29(1):207-211.
PMID: 36573634
In North Carolina, USA, the SARS-CoV-2 Omicron variant was associated with changing symptomology in daily surveys, including increasing rates of self-reported cough and sore throat and decreased rates of loss...
10.
Mongraw-Chaffin M, Tjaden A, Seals A, Miller K, Ahmed N, Espeland M, et al.
J Clin Endocrinol Metab
. 2022 Dec;
PMID: 36482096
Objective: Obesity and diabetes are established risk factors for severe SARS-CoV-2 outcomes, but less is known about their impact on susceptibility to COVID-19 infection and general symptom severity. We hypothesized...